Cargando…

Hepatitis C new drugs

Detalles Bibliográficos
Autor principal:	Wedemeyer, H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The International AIDS Society 2010
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112842/ http://dx.doi.org/10.1186/1758-2652-13-S4-O29

Ejemplares similares

Co-infection with hepatitis C virus (HCV) in Estonian intravenous drug users HIV epidemic
por: Huik, Kristi, et al.
Publicado: (2014)

Hepatitis C — feedback from the Consensus Conference on the Management of Acute Hepatitis C (AHC) in Paris, May 2010
por: Vogel, M
Publicado: (2010)

Raltegravir switch improves hepatitis C transaminitis in HIV-1 and hepatitis C (HCV) co-infected individuals
por: Cevik, Muge, et al.
Publicado: (2012)

Inflammatory patterns in patients with chronic hepatitis C
por: Ion, Daniela Adriana, et al.
Publicado: (2013)

New open drug activity data at EBI
por: Steinbeck, C, et al.
Publicado: (2009)

Metabolic risk factors for liver inflammation in a cohort of chronic hepatitis C patients
por: Rădulescu, Mihaela Andreea, et al.
Publicado: (2014)

P231 HEPATITIS C VIRUS POTENTLY ACTIVATES HUMAN CD161/MAIT (MUCOSAL ASSOCIATED INVARIANT T) CELLS
por: Thompson, F.M., et al.
Publicado: (2014)

Hepatitis C virus fails to activate NF-kappaB signaling in plasmacytoid dendritic cells
por: Stranska, Ruzena, et al.
Publicado: (2012)

New drugs for the control and elimination of malaria: a snapshot of the pipeline
por: Wells, Timothy NC
Publicado: (2012)

Antimalarial drug discovery: targeting the hypnozoite for new radical curative agent
por: Yeung, Bryan
Publicado: (2012)

Influence of liver fibrosis stage on nevirapine plasma concentration in HIV-infected patients with chronic hepatitis C virus
por: Dragovic, Gordana, et al.
Publicado: (2014)

Hepatic lesions
por: Schima, Wolfgang, et al.
Publicado: (2015)

Integrating logic-based machine learning and virtual screening to discover new drugs
por: Reynolds, Christopher R, et al.
Publicado: (2012)

Can we cure ATL: new drugs and targeting ATL stem cells
por: Hermine, Olivier
Publicado: (2014)

Low prevalence of hepatitis C infection among HIV-infected individuals in Slovenia: a nationwide study, 1985–2013
por: Seme, Katja, et al.
Publicado: (2014)

A11 NEXT STEPS IN MICRO-ELIMINATION: PEER POINT OF CARE HEPATITIS C TESTING IN VICTORIA, BRITISH COLUMBIA
por: Barnett, T, et al.
Publicado: (2023)

Hepatic cytolysis and Hepatitis E Virus infection in HIV-positive patients
por: Mazeron, Marie-Christine, et al.
Publicado: (2010)

S6.5c MycetOS: identifying drugs which can penetrate the mycetoma grain
por: Van de Sande, Wendy
Publicado: (2022)

Postpartum evolution of newborns to mothers addicted to “new drugs” and recently diagnosed with HIV infection
por: Ungurianu, Rodica, et al.
Publicado: (2013)

cGMP elevation: new treatment options for lower urinary tract disorders
por: Sandner, Peter
Publicado: (2009)

New mechanisms of normoxic and hypoxic cGMP signalling mediated by the nitrite anion
por: Champion, Hunter
Publicado: (2013)

S8.3c Cell wall glycans as targets for the development of new antifungals
por: Aimanianda, Vishukumar, et al.
Publicado: (2022)

Genetic determinants of hepatitis B vaccine response
por: Png, Eileen, et al.
Publicado: (2011)

A new P. falciparum gametocyte drug screening assay based on pLDH detection
por: D’Alessandro, Sarah, et al.
Publicado: (2012)

Issues in structure-modifying osteoarthritis drug development: new insights regarding radiographic clinical trial methods
por: Beary, JF, et al.
Publicado: (2004)

Causes of mortality among new HIV-infected intravenous drug users in a clinical hospital in Bucharest
por: Erscoiu, Simona, et al.
Publicado: (2013)

P493 Functional genomics in Candida glabrata, new tools to study stress, pathogenesis and drug resistance
por: Usher, Jane
Publicado: (2022)

S1.2c Diagnosis of fungal infections in animals: Combining the old and the new to maximize results
por: Peano, Andrea
Publicado: (2022)

Drug resistance patterns in new and previously treated patients with tuberculosis presenting to a tertiary care center in southern India
por: Udaykumar, Anto J, et al.
Publicado: (2014)

DNA copy number variations in drug reaction with eosinophilia and systemic symptoms (DRESS) identifying 2 new candidates genes
por: Bursztejn, Anne-Claire, et al.
Publicado: (2014)

PReS-FINAL-2173: Protein kinase C delta deficiency is a new cause of monogenic SLE
por: Belot, A, et al.
Publicado: (2013)

Is learning drugs the same as learning non-drugs?
por: Brown, Robert D, et al.
Publicado: (2008)

The MONET trial: correlation between Hepatitis C coinfection and HIV RNA responses during darunavir/ritonavir monotherapy, for patients with HIV RNA <50 copies/mL at baseline
por: Arribas, Jose R, et al.
Publicado: (2010)

Strategies of drug companies to optimize the sales of their psychiatric drugs
por: Whitaker, Robert
Publicado: (2007)

Distinctive personality patterns in patients with chronic viral hepatitis
por: Cercel, Ioana-Catrinel, et al.
Publicado: (2014)

HIV stigma in Romania – from the generation of nosocomially-infected children to the new generation of injecting drug users. Results from a qualitative study
por: Lazar, Florin
Publicado: (2014)

Morbidity associated with hepatitis E virus infection in endemic setting
por: Favorov, Michael, et al.
Publicado: (2010)

Abstracts of the Australasian Viral Hepatitis Elimination Conference: oral presentations
Publicado: (2017)

Chemoinformatics in drug development
por: Groom, Colin R
Publicado: (2012)

Benefits of combined treatments using antiresorptive agents and cytotoxic drugs
por: Holen, I, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_5voqvj6shu363haaka8bei4171